Reuters logo
10 months ago
BRIEF-Ampio says met with FDA for Ampion biological license
September 29, 2016 / 7:06 PM / 10 months ago

BRIEF-Ampio says met with FDA for Ampion biological license

1 Min Read

Sept 29 (Reuters) - Ampio Pharmaceuticals Inc:

* Ampio updates clinical and regulatory activity

* Has met with CBER division of FDA to seek guidance on best path forward to obtain a biological license for Ampion

* Reported completion of enrollment for AP-011 sudy to evaluate safety of single intra-articular injection of Ampion for basal thumb arthritis Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below